Asset Details
Do you wish to reserve the book?
Antimicrobial resistance and COVID-19: Intersections and implications
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Antimicrobial resistance and COVID-19: Intersections and implications
Do you wish to request the book?
Antimicrobial resistance and COVID-19: Intersections and implications
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Antimicrobial resistance and COVID-19: Intersections and implications
2021
Overview
Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR) was among the top priorities for global public health. Already a complex challenge, AMR now needs to be addressed in a changing healthcare landscape. Here, we analyse how changes due to COVID-19 in terms of antimicrobial usage, infection prevention, and health systems affect the emergence, transmission, and burden of AMR. Increased hand hygiene, decreased international travel, and decreased elective hospital procedures may reduce AMR pathogen selection and spread in the short term. However, the opposite effects may be seen if antibiotics are more widely used as standard healthcare pathways break down. Over 6 months into the COVID-19 pandemic, the dynamics of AMR remain uncertain. We call for the AMR community to keep a global perspective while designing finely tuned surveillance and research to continue to improve our preparedness and response to these intersecting public health challenges.
Publisher
eLife Science Publications, Ltd,eLife Sciences Publications Ltd,eLife Sciences Publications, Ltd
Subject
Anti-Bacterial Agents - supply & distribution
/ Anti-Bacterial Agents - therapeutic use
/ Communicable Disease Control - methods
/ Communicable Disease Control - organization & administration
/ COVID-19
/ COVID-19 - prevention & control
/ Critical Pathways - organization & administration
/ Drug resistance in microorganisms
/ Drug Resistance, Bacterial - physiology
/ Epidemiology and Global Health
/ Humans
/ Hygiene
/ Malaria
/ Patients
/ Review
